Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dooijewaard

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Thrombosis and Haemostasis|June 1, 1996
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluidsE A Braat, U Nauland, G Dooijewaard, et al.
Annals of the Rheumatic Diseases|August 1, 1992
Plasminogen activators in synovial fluid and plasma from patients with arthritisE J Brommer, G Dooijewaard, B A Dijkmans, et al.
Thrombosis and Haemostasis|November 15, 1993
Parameters of fibrinolysis in peritoneal fluid and plasma in different stages of the menstrual cycleP J Dörr, E J Brommer, G Dooijewaard, et al.
Annals of Hematology|January 1, 1994
Impaired fibrinolysis in the hemolytic-uremic syndrome of childhoodD Menzel, M Levi, G Dooijewaard, et al.
Thrombosis and Haemostasis|August 13, 1990
Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agentsD C Rijken, E Seifried, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|August 3, 1992
Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory diseaseP J Dörr, E J Brommer, G Dooijewaard, et al.
Thrombosis and Haemostasis|August 3, 1992
Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammationE J Brommer, G Dooijewaard, B A Dijkmans, et al.
Biochimica Et Biophysica Acta|February 7, 1977
EPR signals of NADH: Q oxidoreductase. Shape and intensityS P Albracht, G Dooijewaard, F J Leeuwerik, et al.
Blood|May 15, 1990
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cellsV W van Hinsbergh, E A van den Berg, W Fiers, et al.
Thrombosis and Haemostasis|January 1, 1994
Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotininG Himmelreich, G Dooijewaard, P Neuhaus, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Thrombosis and Haemostasis|June 1, 1996
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluidsE A Braat, U Nauland, G Dooijewaard, et al.
Annals of the Rheumatic Diseases|August 1, 1992
Plasminogen activators in synovial fluid and plasma from patients with arthritisE J Brommer, G Dooijewaard, B A Dijkmans, et al.
Thrombosis and Haemostasis|November 15, 1993
Parameters of fibrinolysis in peritoneal fluid and plasma in different stages of the menstrual cycleP J Dörr, E J Brommer, G Dooijewaard, et al.
Annals of Hematology|January 1, 1994
Impaired fibrinolysis in the hemolytic-uremic syndrome of childhoodD Menzel, M Levi, G Dooijewaard, et al.
Thrombosis and Haemostasis|August 13, 1990
Plasminogen activation at low temperatures in plasma samples containing therapeutic concentrations of tissue-type plasminogen activator or other thrombolytic agentsD C Rijken, E Seifried, M M Barrett-Bergshoeff, et al.
Thrombosis and Haemostasis|August 3, 1992
Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory diseaseP J Dörr, E J Brommer, G Dooijewaard, et al.
Thrombosis and Haemostasis|August 3, 1992
Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammationE J Brommer, G Dooijewaard, B A Dijkmans, et al.
Biochimica Et Biophysica Acta|February 7, 1977
EPR signals of NADH: Q oxidoreductase. Shape and intensityS P Albracht, G Dooijewaard, F J Leeuwerik, et al.
Blood|May 15, 1990
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cellsV W van Hinsbergh, E A van den Berg, W Fiers, et al.
Thrombosis and Haemostasis|January 1, 1994
Increased urokinase-type plasminogen activator (u-PA) levels in graft liver perfusate and decreased single chain u-PA activation with higher levels of aprotininG Himmelreich, G Dooijewaard, P Neuhaus, et al.
Pageof 5